Insights into the Reaction of Protein-tyrosine Phosphatase 1B

Catalysis by protein-tyrosine phosphatase 1B (PTP1B) occurs through a two-step mechanism involving a phosphocysteine intermediate. We have solved crystal structures for the transition state analogs for both steps. Together with previously reported crystal structures of apo-PTP1B, the Michaelis complex of an inactive mutant, the phosphoenzyme intermediate, and the product complex, a full picture of all catalytic steps can now be depicted. The transition state analog for the first catalytic step comprises a ternary complex between the catalytic cysteine of PTP1B, vanadate, and the peptide DADEYL, a fragment of a physiological substrate. The equatorial vanadate oxygen atoms bind to the P-loop, and the apical positions are occupied by the peptide tyrosine oxygen and by the PTP1B cysteine sulfur atom. The vanadate assumes a trigonal bipyramidal geometry in both transition state analog structures, with very similar apical O–O distances, denoting similar transition states for both phosphoryl transfer steps. Detailed interactions between the flanking peptide and the enzyme are discussed.

[1]  M. Gresser,et al.  Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate* , 1997, The Journal of Biological Chemistry.

[2]  M. Gresser,et al.  Interaction of inorganic vanadate with glucose-6-phosphate dehydrogenase. Nonenzymic formation of glucose 6-vanadate. , 1985, The Journal of biological chemistry.

[3]  D. Barford,et al.  Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography* , 1998, The Journal of Biological Chemistry.

[4]  D. Herschlag,et al.  Kinetic isotope effects for alkaline phosphatase reactions: implications for the role of active-site metal ions in catalysis. , 2007, Journal of the American Chemical Society.

[5]  D. Barford,et al.  Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. , 1995, Science.

[6]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[7]  P G Drake,et al.  Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.

[8]  C. Hellberg,et al.  Protein-tyrosine phosphatases and cancer , 2006, Nature Reviews Cancer.

[9]  J. Morrow,et al.  Altered transition state for the reaction of an RNA model catalyzed by a dinuclear zinc(II) catalyst. , 2008, Journal of the American Chemical Society.

[10]  J. Kastrup,et al.  Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis. , 2004, The Biochemical journal.

[11]  A. Hengge Isotope effects in the study of phosphoryl and sulfuryl transfer reactions. , 2002, Accounts of chemical research.

[12]  S. Sprang,et al.  Transition state structures and the roles of catalytic residues in GAP-facilitated GTPase of Ras as elucidated by (18)O kinetic isotope effects. , 2009, Biochemistry.

[13]  M. Eberlin,et al.  Intramolecular acid-base catalysis of a phosphate diester: modeling the ribonuclease mechanism. , 2008, Journal of the American Chemical Society.

[14]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[15]  D. Herschlag,et al.  Impaired transition state complementarity in the hydrolysis of O-arylphosphorothioates by protein-tyrosine phosphatases. , 1999, Biochemistry.

[16]  Zhon-Yin Zhang,et al.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. , 2002, Annual review of pharmacology and toxicology.

[17]  E. Fauman,et al.  Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate , 1994, Nature.

[18]  Sheng Zhang,et al.  PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. , 2007, Drug discovery today.

[19]  E. Fauman,et al.  The X-ray Crystal Structures of Yersinia Tyrosine Phosphatase with Bound Tungstate and Nitrate , 1996, The Journal of Biological Chemistry.

[20]  Jeffrey P. Jones,et al.  Secondary 18O isotope effects for hexokinase-catalyzed phosphoryl transfer from ATP. , 1991, Biochemistry.

[21]  D. Barford,et al.  The structure and mechanism of protein phosphatases: insights into catalysis and regulation. , 1998, Annual review of biophysics and biomolecular structure.

[22]  L. Iversen,et al.  2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine Phosphatases* , 2000, The Journal of Biological Chemistry.

[23]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[24]  L. Wu,et al.  Effects on general acid catalysis from mutations of the invariant tryptophan and arginine residues in the protein tyrosine phosphatase from Yersinia. , 2000, Biochemistry.

[25]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[26]  R. Wolfenden,et al.  The rate of hydrolysis of phosphomonoester dianions and the exceptional catalytic proficiencies of protein and inositol phosphatases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Hengge,et al.  Altered mechanisms of reactions of phosphate esters bridging a dinuclear metal center. , 2004, Journal of the American Chemical Society.

[28]  D. Crans,et al.  The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. , 2004, Chemical reviews.

[29]  E. Fauman,et al.  A ligand‐induced conformational change in the yersinia protein tyrosine phosphatase , 1995, Protein science : a publication of the Protein Society.

[30]  D S Lawrence,et al.  Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition. , 2000, Biochemistry.

[31]  F. Haj,et al.  Regulation of Receptor Tyrosine Kinase Signaling by Protein Tyrosine Phosphatase-1B* , 2003, The Journal of Biological Chemistry.

[32]  Sean J. Johnson,et al.  Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures. , 2009, Journal of the American Chemical Society.

[33]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[34]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[35]  Y. Zhao,et al.  Reactivity of alcohols toward the phosphoenzyme intermediate in the protein-tyrosine phosphatase-catalyzed reaction: probing the transition state of the dephosphorylation step. , 1996, Biochemistry.

[36]  J. Dixon,et al.  Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. , 1991, The Journal of biological chemistry.

[37]  D. Dunaway-Mariano,et al.  The catalytic scaffold of the haloalkanoic acid dehalogenase enzyme superfamily acts as a mold for the trigonal bipyramidal transition state , 2008, Proceedings of the National Academy of Sciences.

[38]  D. Lawrence,et al.  Acquisition of a Specific and Potent PTP1B Inhibitor from a Novel Combinatorial Library and Screening Procedure* , 2001, The Journal of Biological Chemistry.

[39]  D. Lawrence,et al.  Probing the Molecular Basis for Potent and Selective Protein-tyrosine Phosphatase 1B Inhibition* , 2002, The Journal of Biological Chemistry.

[40]  P. Nordlund,et al.  Energetics of nucleophile activation in a protein tyrosine phosphatase. , 1997, Journal of molecular biology.

[41]  L. Wu,et al.  Probing the function of the conserved tryptophan in the flexible loop of the Yersinia protein-tyrosine phosphatase. , 2008, European journal of biochemistry.

[42]  K. Peters,et al.  Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. , 2006, Acta crystallographica. Section D, Biological crystallography.

[43]  A. Hengge,et al.  CONCERTED OR STEPWISE MECHANISMS FOR ACYL TRANSFER REACTIONS OF P-NITROPHENYL ACETATE ? TRANSITION STATE STRUCTURES FROM ISOTOPE EFFECTS , 1994 .

[44]  J. Denu,et al.  Molecular Reactions of Protein PhosphatasesInsights from Structure and Chemistry , 2001 .

[45]  J. Goodman,et al.  Intramolecular general acid catalysis of phosphate transfer. nucleophilic attack by oxyanions on the PO3 2- group. , 2005, Journal of the American Chemical Society.

[46]  D. Barford,et al.  Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. , 2000, Molecular cell.

[47]  B. Finlay,et al.  Phosphatases and kinases delivered to the host cell by bacterial pathogens. , 2000, Trends in microbiology.

[48]  D. Barford,et al.  Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase. , 2005, Structure.

[49]  N. Reiner,et al.  Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. , 2005, Clinical immunology.

[50]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[51]  J. Åqvist,et al.  Computational modeling of the rate limiting step in low molecular weight protein tyrosine phosphatase , 1999, FEBS letters.

[52]  L. Wu,et al.  Nature of the transition state of the protein-tyrosine phosphatase-catalyzed reaction. , 1995, Biochemistry.

[53]  L. Wu,et al.  Examination of the transition state of the low-molecular mass small tyrosine phosphatase 1. Comparisons with other protein phosphatases. , 1997, Biochemistry.

[54]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[55]  D. Barford,et al.  Crystal structure of human protein tyrosine phosphatase 1B. , 1994, Science.

[56]  Jay Painter,et al.  Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .

[57]  D. Barford,et al.  Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. , 1994, Journal of molecular biology.

[58]  T. Burke,et al.  High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. , 2003, Biochemistry.

[59]  H. Waldmann,et al.  Inhibitors of protein tyrosine phosphatases: next-generation drugs? , 2005, Angewandte Chemie.

[60]  J. Ermolieff,et al.  Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.

[61]  J. Dixon,et al.  Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. , 1993, Biochemistry.

[62]  Peter Briggs,et al.  A graphical user interface to the CCP4 program suite. , 2003, Acta crystallographica. Section D, Biological crystallography.

[63]  J. Kastrup,et al.  Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B. , 2004, Acta crystallographica. Section D, Biological crystallography.

[64]  D. Bashford,et al.  Density functional study of the mechanism of a tyrosine phosphatase: I. Intermediate formation. , 2002, Journal of the American Chemical Society.

[65]  J. Dixon,et al.  Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[66]  V. J. Shiner Reaction Rates of Isotopic Molecules , 1981 .

[67]  M. Zhou,et al.  Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate. , 1997, Biochemistry.

[68]  Jiali Gao,et al.  Walden-Inversion-Enforced Transition-State Stabilization in a Protein Tyrosine Phosphatase , 1998 .

[69]  W. Huskey Isotope Effects in Chemistry and Biology , 2006 .

[70]  J. Baell,et al.  Phosphate isosteres in medicinal chemistry. , 2005, Current medicinal chemistry.

[71]  Richard L. Pederson,et al.  Reversible and in situ formation of organic arsenates and vanadates as organic phosphate mimics in enzymatic reactions: mechanistic investigation of aldol reactions and synthetic applications , 1989 .

[72]  Z. Zhang,et al.  Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis. , 1998, Critical reviews in biochemistry and molecular biology.

[73]  W. Hol,et al.  The power of vanadate in crystallographic investigations of phosphoryl transfer enzymes , 2004, FEBS letters.

[74]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[75]  F. Hollfelder,et al.  A Trojan horse transition state analogue generated by MgF3− formation in an enzyme active site , 2006, Proceedings of the National Academy of Sciences.

[76]  R. Schowen,et al.  Transition States of Biochemical Processes , 1978, Springer US.